WallStreetZenWallStreetZen

NASDAQ: GNTA
Genenta Science Spa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GNTA

Based on 1 analyst offering 12 month price targets for Genenta Science Spa.
Min Forecast
$25.00+419.75%
Avg Forecast
$25.00+419.75%
Max Forecast
$25.00+419.75%

Should I buy or sell GNTA stock?

Based on 1 analyst offering ratings for Genenta Science Spa.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GNTA stock forecasts and price targets.

GNTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-02

1 of 1

Forecast return on equity

Is GNTA forecast to generate an efficient return?
Company
38.55%
Industry
-748.45%
Market
49.39%
GNTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GNTA forecast to generate an efficient return on assets?
Company
35.25%
Industry
26.75%
GNTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GNTA earnings per share forecast

What is GNTA's earnings per share in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.93
Avg 2 year Forecast
-$1.09
Avg 3 year Forecast
-$1.12

GNTA revenue forecast

What is GNTA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$84.1M
Avg 2 year Forecast
$190.2M
Avg 3 year Forecast
$364.8M

GNTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNTA$4.81$25.00+419.75%Buy
IVA$1.69$18.00+965.09%Strong Buy
ARMP$2.40$7.00+191.67%Buy
GNLX$2.51$22.33+789.76%Strong Buy
EPRX$2.49N/AN/A
View Top Biotech Stocks

Genenta Science Spa Stock Forecast FAQ

Is Genenta Science Spa Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GNTA) stock is to Buy GNTA stock.

Out of 1 analyst, 0 (0%) are recommending GNTA as a Strong Buy, 1 (100%) are recommending GNTA as a Buy, 0 (0%) are recommending GNTA as a Hold, 0 (0%) are recommending GNTA as a Sell, and 0 (0%) are recommending GNTA as a Strong Sell.

If you're new to stock investing, here's how to buy Genenta Science Spa stock.

What is GNTA's earnings growth forecast for 2024-2026?

(NASDAQ: GNTA) Genenta Science Spa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.77%.

Genenta Science Spa's earnings in 2024 is -$12,658,103.On average, 1 Wall Street analyst forecast GNTA's earnings for 2024 to be -$16,941,771, with the lowest GNTA earnings forecast at -$16,941,771, and the highest GNTA earnings forecast at -$16,941,771. On average, 1 Wall Street analyst forecast GNTA's earnings for 2025 to be -$19,856,484, with the lowest GNTA earnings forecast at -$19,856,484, and the highest GNTA earnings forecast at -$19,856,484.

In 2026, GNTA is forecast to generate -$20,402,993 in earnings, with the lowest earnings forecast at -$20,402,993 and the highest earnings forecast at -$20,402,993.

What is GNTA's revenue growth forecast for 2027-2029?

(NASDAQ: GNTA) Genenta Science Spa's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.42%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.66%.

Genenta Science Spa's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast GNTA's revenue for 2027 to be $1,531,499,659, with the lowest GNTA revenue forecast at $1,531,499,659, and the highest GNTA revenue forecast at $1,531,499,659. On average, 1 Wall Street analysts forecast GNTA's revenue for 2028 to be $3,465,594,090, with the lowest GNTA revenue forecast at $3,465,594,090, and the highest GNTA revenue forecast at $3,465,594,090.

In 2029, GNTA is forecast to generate $6,644,635,431 in revenue, with the lowest revenue forecast at $6,644,635,431 and the highest revenue forecast at $6,644,635,431.

What is GNTA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: GNTA) forecast ROA is 35.25%, which is higher than the forecast US Biotechnology industry average of 26.75%.

What is GNTA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GNTA price target, the average GNTA price target is $25.00, with the highest GNTA stock price forecast at $25.00 and the lowest GNTA stock price forecast at $25.00.

The Wall Street analyst predicted that Genenta Science Spa's share price could reach $25.00 by Oct 2, 2025. The average Genenta Science Spa stock price prediction forecasts a potential upside of 419.75% from the current GNTA share price of $4.81.

What is GNTA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: GNTA) Genenta Science Spa's current Earnings Per Share (EPS) is -$0.70. On average, analysts forecast that GNTA's EPS will be -$0.93 for 2024, with the lowest EPS forecast at -$0.93, and the highest EPS forecast at -$0.93. On average, analysts forecast that GNTA's EPS will be -$1.09 for 2025, with the lowest EPS forecast at -$1.09, and the highest EPS forecast at -$1.09. In 2026, GNTA's EPS is forecast to hit -$1.12 (min: -$1.12, max: -$1.12).

What is GNTA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: GNTA) forecast ROE is 38.55%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.